Navigation Links
MINRAD Receives Notice That NYSE Alternext Intends to File Delisting Application With Securities and Exchange Commission
Date:2/6/2009

ORCHARD PARK, N.Y., Feb. 6 /PRNewswire-FirstCall/ -- MINRAD International, Inc. (Amex: BUF) -- On February 2, 2009, the Company received a notice from NYSE Alternext US LLC (the "Exchange") stating that the Exchange intends to strike the common stock of the Company from the Exchange by filing a delisting application with the Securities and Exchange Commission pursuant to Section 1009(d) of the NYSE Alternext US Company Guide. By letter dated December 11, 2008, the Exchange had advised the Company that the Company was not in compliance with certain provision of the Exchange's Company Guide (the "Company Guide"), namely Section 1003(a)(i), with stockholders' equity of less than $2,000,000 and losses from continuing operations and net losses in two out of its three most recent fiscal years; 1003(a)(ii), with stockholders' equity of less than $4,000,000 and losses from continuing operations and net losses in three out of its four most recent fiscal years; 1003(a)(iii), with stockholders' equity of less than $6,000,000 and losses from continuing operations and net losses in its five most recent fiscal years; and 1003(a)(iv) in that it has sustained losses which are so substantial in relation to its overall operations or its existing financial resources, or its financial condition has become so impaired that it appears questionable, in the opinion of the Exchange, as to whether it will be able to continue operations and/or meet its obligations as they mature.

By letter dated December 26, 2008 the Company notified the staff it had entered into a definitive merger agreement with Piramal Healthcare, Inc., Piramal Healthcare Limited and Mayflower Acquisition Corp. for the acquisition of the Company and requested that the Exchange continue to list the Company's stock until consummation of that merger, at which time the Company would vo
'/>"/>

SOURCE MINRAD International, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. MINRAD International, Inc. Announces Reduction in Workforce
2. MINRAD International, Inc. to Discuss 2008 First Quarter Financial Results on Tuesday, May 13, 2008
3. MINRAD International, Inc. Announces $40.0 Million Private Placement
4. MINRAD International, Inc. Announces Appointment of David T. DiGiacinto as President and Chief Operating Officer
5. Victhom Human Bionics Receives CE Mark for the Neurostep(TM) System, the Worlds First Fully Implantable Closed-Loop Neuromodulation Therapy for Treatment of Foot Drop
6. Fraunhofer USA Center for Molecular Biotechnology Receives Gates Foundation Grant for Avian Influenza Vaccine Development
7. AdvanDx Receives FDA 510(k) Clearance for E. coli/P. aeruginosa PNA FISH(R)
8. Dow AgroSciences Receives Approval for Cultivation of HERCULEX(R) I Corn in Brazil
9. Cell Therapeutics Receives Additional NASDAQ Notification
10. Neuralstem Receives Final Notice of Allowance for New Stem Cell Immortalization Technology Patent
11. Victhom Human Bionics Neurobionix Division receives ISO 13485:2003 Certification for its Design Control System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)DALLAS, Dec. 3 ACCESS PHARMACEUTICALS, INC. (OTC Bulletin Board: ACCP), today provided an update on its European commercial launch of MuGard, an FDA approved treatment for oral mucositis, a deb
(Date:12/3/2009)PHILADELPHIA, Dec. 3 Shire plc (LSE: SHP, Nasdaq: SHPGY ), the global specialty biopharmaceutical company, today announced a voluntary recall of five lots and voluntary market withdrawal of one lot
(Date:12/3/2009)WALTHAM, Mass., Dec. 3 Inverness Medical Innovations, Inc. (NYSE: IMA ), a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and h
(Date:12/3/2009)NEW DELHI, India, Dec. 3 /PRNewswire-Asia/ -- Dr. Susan Jiang, M.D., Ph.D.,Chief Science Officer at Shenzhen Beike Biotechnology Co. Ltd.,( http://www.beikebiotech.com ), spoke at a conference on Hig
Breaking Biology Technology:Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 2Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 3Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 4Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 2Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 3Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 4Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 5Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 2Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 3
...ing the participation of the Consejo Superior de I...e experiment of Thomas Young in a molecule of hydr...n 1803 the English scientist tested a pattern of i...ssing through a double slit and thus being refract...ad wave motion properties. The authors of this cur...
...t 1:30 PM ET -, SEATTLE, Nov. 15 Dendreon Corpor...the quarter ended September 30,2007. Revenue for t...$84,000 for the quarter ended September 30, 2006. ...07 was $715,000 compared to $187,000 for the,nine ... operating expenses for the third quarter of 2007 ...
...E ),today announced that its Board of Directors ha...ate Officer effective immediately. Mr. Davidson wi...l Audit. He has held several,key corporate and div...any,in 1984. These include serving as Vice Preside...nsumer Healthcare and Deputy Treasurer, Wyeth. Pr...
Other Biology Technology:Young's experiment in a hydrogen molecule 2Dendreon Reports Third Quarter 2007 Financial Results 2Dendreon Reports Third Quarter 2007 Financial Results 3Dendreon Reports Third Quarter 2007 Financial Results 4Dendreon Reports Third Quarter 2007 Financial Results 5
(Date:12/3/2009)Have you ever felt overly upset by a social snubbing? Your genetics, not your friends, may be at fault. , Scientists have long known that opium-like painkillers, called opioids, relieve not only phys
(Date:12/3/2009)Spanish researchers have measured CO2 levels for the past three years in the troposphere (lower atmosphere) over a sparsely inhabited rural area near Valladolid. The results, which are the first of th
(Date:12/3/2009)UPTON, NY A team of scientists from the U.S. Department of Energy,s (DOE) Brookhaven National Laboratory, Harvard University, and the Indian Institute of Science has made a major step in understandin
Breaking Biology News(10 mins):CO2 levels rising in troposphere over rural areas 2Grooving down the helix 2Grooving down the helix 3St Davids South Austin Hospital Leading the Central Texas Region in Laser Assisted Lead Extraction Procedures 5886 1St Davids South Austin Hospital Leading the Central Texas Region in Laser Assisted Lead Extraction Procedures 5886 2St Davids South Austin Hospital Leading the Central Texas Region in Laser Assisted Lead Extraction Procedures 5886 3London Genetics Focuses on Partnering Following Successful Pharmacogenetics Conference 5884 1London Genetics Focuses on Partnering Following Successful Pharmacogenetics Conference 5884 2London Genetics Focuses on Partnering Following Successful Pharmacogenetics Conference 5884 3London Genetics Focuses on Partnering Following Successful Pharmacogenetics Conference 5884 4Leave It To Beaver Star Visits Kannapolis to Promote Prescription Assistance 5882 1Leave It To Beaver Star Visits Kannapolis to Promote Prescription Assistance 5882 2
...dy led by an eminent molecular biologist at Florid...at as embryonic stem cells turn into different cel...to the order in which DNA is replicated and reorga... gap for stem cell biologists, enabling them to be...which DNA is repackaged during differentiation -- ...
...d not only how we find or share information, but a...ed by the National Institutes of Health plans to t..., The University of Michigan will lead the effort...o develop computer programs that more accurately p... housed in a Web-based resource that the scientifi...
...Doyle today announced a historic collaboration bet...ce personalized health care leading to health care...n Genomics Initiative is a collaborative research ...e of Wisconsin (MCW), University of Wisconsin Scho...ilwaukee (UWM). , Wisconsin is a leader in genomi...
Other Biology News:Landmark study unlocks stem cell, DNA secrets to speed therapies 2Landmark study unlocks stem cell, DNA secrets to speed therapies 3New data resource to advance computer-aided drug design 2Governor Doyle announces historic genomic research collaboration 2
SURE E. coli Strain from Stratagene
21-mer duplex from B-Bridge International
...dy to CRF The antibody blocks specificially with ... Cells and fibres are found in the paraventricular...reated 4% FA perfused tissue. Immunogen: CRF: ...s-Leu-Leu-Arg-Glu-Val-Leu-Glu-Met-Thr-Lys-Ala-Asp-...
JM101 E. coli Strain from Stratagene
Biology Products: